IRCT138904121760N8已完成2 期
Comparison of adding Tamoxifen or Gonadotropin to Clomiphene for induction ovulation in Polycystic Ovary Syndrome (PCOS) patients resistance to Clomiphene
Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 35 years（—）
- 性别
- Female
入选标准
- •PCOS Clomiphen citrate resistance Patients with age between 18 and 35 years, years period of infertility between 1.5-5 yr and BMI between 19-35. Exclusion criteria: hyperprolactinaemia, hypercorticism or thyroidism, pelvic pathology or surgery, infertility factor other than anovulation excluded.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Evaluation of the effects of increasing tamoxifen dose on the treatment process in breast cancer patientsBreast cancer.Malignant neoplasm of breastIRCT2015082323734N1Isfahan University of Medical Siences100
招募中
不适用
T&T trial: adding Testosterone to Tamoxifen in male breast cancer patientsmale breast cancer10006291NL-OMON51371niversitair Medisch Centrum Groningen6
进行中（未招募）
1 期
T&T trial: adding Testosterone to Tamoxifen in male breast cancer patientsmale breast cancer patientsEUCTR2021-002170-72-NLniversity Medical Center Groningen6
已完成
2 期
Randomized study of tamoxifen versus goserelin acetate vs combination as preoperative endocrine therapy for estrogen receptor positive pre-menopausal patients.Estrogen receptor positive, pre-menopausal breast cancerJPRN-UMIN000006286Yokohama City University Medical Center220
尚未招募
4 期
A study to find best medicine and its dose for the treatment of breast pain.CTRI/2018/02/012043HLL lifecare Ltd